staurosporine has been researched along with Chromosome Deletion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelopoulou, MK; Chatzidimitriou, C; Konstantopoulos, K; Korkolopoulou, P; Lafioniatis, S; Lakiotaki, E; Pappa, V; Plata, E; Vassilakopoulos, TP | 1 |
| Cools, J | 1 |
| Grenet, J; Kidd, VJ; Lahti, JM; Liu, D; Teitz, T; Valentine, M; Valentine, V; Wei, T | 1 |
| Anderson, CM; Olefsky, JM | 1 |
4 other study(ies) available for staurosporine and Chromosome Deletion
| Article | Year |
|---|---|
Pancytopenia, eosinophilia and coagulation disorders in a patient with T-acute lymphoblastic leukemia in prolonged remission.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Biomarkers, Tumor; Blood Cell Count; Bone Marrow; Cancer Survivors; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Diagnosis, Differential; Eosinophilia; Hemorrhagic Disorders; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Male; Mastocytosis, Systemic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pancytopenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Staurosporine; Tryptases | 2021 |
The hypereosinophilic syndrome: idiopathic or not, that is the question.
Topics: Antineoplastic Agents; Benzamides; Chromosome Deletion; Chromosomes, Human, Pair 4; Chronic Disease; Clone Cells; Diagnosis, Differential; Drug Resistance, Neoplasm; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Lymphoproliferative Disorders; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Piperazines; Point Mutation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Staurosporine; T-Lymphocyte Subsets | 2005 |
Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Topics: Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-X Protein; Caspase 9; Caspases; Chromosome Deletion; Chromosomes, Human, Pair 1; Cytochrome c Group; DNA Primers; Enzyme Inhibitors; Gene Amplification; Genes, myc; Humans; Immunoblotting; In Situ Hybridization, Fluorescence; Loss of Heterozygosity; Microsatellite Repeats; Neuroblastoma; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Staurosporine; Transcription, Genetic; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors.
Topics: Alkaloids; Animals; Cell Line; Chromosome Deletion; Glucose; Glycogen; Humans; Insulin; Kinetics; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Receptor, Insulin; Sp1 Transcription Factor; Staurosporine; Tetradecanoylphorbol Acetate; Transfection | 1991 |